These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6249997)

  • 1. The direction of opiodid agonists towards mu-, delta- and epsilon-receptors in the vas deferens of the mouse and the rat.
    Wüster M; Schulz R; Herz A
    Life Sci; 1980 Jul; 27(2):163-70. PubMed ID: 6249997
    [No Abstract]   [Full Text] [Related]  

  • 2. The mu, kappa and delta properties of various opioid agonists.
    Takemori AE; Ikeda M; Portoghese PS
    Eur J Pharmacol; 1986 Apr; 123(3):357-61. PubMed ID: 3013652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly specific opiate receptors for dynorphin-(1-13) in the mouse vas deferens.
    Wüster M; Schulz R; Herz A
    Eur J Pharmacol; 1980 Mar; 62(2-3):235-6. PubMed ID: 6103811
    [No Abstract]   [Full Text] [Related]  

  • 4. Specificity of opioids towards the mu-, delta- and epsilon-opiate receptors.
    Wüster M; Schulz R; Herz A
    Neurosci Lett; 1979 Dec; 15(2-3):193-8. PubMed ID: 231238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of opioid receptor ligands on the mu-S196A knock-in and mu knockout mouse vas deferens.
    Portoghese PS; Law PY; Loh HH
    Eur J Pharmacol; 2003 Oct; 478(2-3):207-10. PubMed ID: 14575806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptor.
    Corbett AD; Gillan MG; Kosterlitz HW; McKnight AT; Paterson SJ; Robson LE
    Br J Pharmacol; 1984 Sep; 83(1):271-9. PubMed ID: 6091824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The choice of opioid receptor subtype in isolated preparations by ohmefentanyl.
    Jin WQ; Chen XJ; Chi ZQ
    Sci Sin B; 1987 Feb; 30(2):176-81. PubMed ID: 3039656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of delta-opioid receptors in the hamster vas deferens.
    Sheehan MJ; Hayes AG; Tyers MB
    Eur J Pharmacol; 1986 Oct; 130(1-2):57-64. PubMed ID: 3023115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in vitro pharmacology of D-Met2,Pro5-enkephalinamide.
    Rónai AZ; Berzétei IP; Bajusz S; Székely JI
    J Pharm Pharmacol; 1981 Aug; 33(8):534-5. PubMed ID: 6115930
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of enkephalin and endorphin analogs on receptors in the mouse vas deferens.
    Britton DR; Fertel R; Coy DH; Kastin AJ
    Biochem Pharmacol; 1978; 27(18):2275-7. PubMed ID: 215153
    [No Abstract]   [Full Text] [Related]  

  • 11. Demonstration of the crucial role of the phenylalanine moiety in enkephalin analogues for differential recognition of the mu- and delta-receptors.
    Roques BP; Gacel G; Fournie-Zaluski MC; Senault B; Lecomte JM
    Eur J Pharmacol; 1979 Nov; 60(1):109-10. PubMed ID: 230063
    [No Abstract]   [Full Text] [Related]  

  • 12. Photoaffinity labeling of opioid receptor with morphine-7,8-oxide (morphine epoxide).
    Takayanagi I; Shibata R; Miyata N; Hirobe M
    J Pharmacol Methods; 1982 May; 7(3):185-92. PubMed ID: 6287114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of potassium on the potency of different opioids in the mouse vas deferens.
    Wüster M; Schulz R
    Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(2):181-4. PubMed ID: 7207646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of cross-tolerance on multiple opiate receptors in the mouse vas deferens.
    Schulz R; Wüster M; Krenss H; Herz A
    Mol Pharmacol; 1980 Nov; 18(3):395-401. PubMed ID: 6258048
    [No Abstract]   [Full Text] [Related]  

  • 15. Opiate agonists inhibit noradrenaline release via opiate B-receptors and N-cyclopropylmethylnorazidomorphine (CAM) blocks electrically evoked contractions via histamine in the mouse vas deferens.
    Knoll J; Kerecsen L; Somogyi GT; Kovács A
    Arch Int Pharmacodyn Ther; 1981 May; 251(1):52-65. PubMed ID: 6266359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profile of activity of kappa receptor agonists in the rabbit vas deferens.
    Hayes A; Kelly A
    Eur J Pharmacol; 1985 Apr; 110(3):317-22. PubMed ID: 2988982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A series of novel, highly potent and selective agonists for the kappa-opioid receptor.
    Hayes AG; Birch PJ; Hayward NJ; Sheehan MJ; Rogers H; Tyers MB; Judd DB; Scopes DI; Naylor A
    Br J Pharmacol; 1990 Dec; 101(4):944-8. PubMed ID: 1964823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The opioid receptors in the hamster vas deferens are of the delta-type.
    McKnight AT; Corbett AD; Marcoli M; Kosterlitz HW
    Neuropharmacology; 1985 Nov; 24(11):1011-7. PubMed ID: 3001569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation between rat brain and mouse vas deferens delta opioid receptors.
    Vaughn LK; Wire WS; Davis P; Shimohigashi Y; Toth G; Knapp RJ; Hruby VJ; Burks TF; Yamamura HI
    Eur J Pharmacol; 1990 Feb; 177(1-2):99-101. PubMed ID: 2160370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of mu- and delta-opioid agonists in vas deferens from mice deficient in MOR gene.
    Maldonado R; Severini C; Matthes HW; Kieffer BL; Melchiorri P; Negri L
    Br J Pharmacol; 2001 Apr; 132(7):1485-92. PubMed ID: 11264242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.